Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur Rev Med Pharmacol Sci ; 25(1 Suppl): 43-48, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34890033

RESUMEN

OBJECTIVE: Lemna minor is a plant with a huge repertoire of secondary metabolites. The literature indicates that extracts of Lemna minor have antioxidant, antiradical, immunomodulatory and anti-inflammatory properties. The objective of the present study was to find a suitable technique to extract active compounds from this plant and verify whether these extracts have immunomodulatory activity. MATERIALS AND METHODS: We grew L. minor on a standard medium with Gamborg B5 and vitamins. We extracted compounds from the plant by maceration and decoction. The phytochemical profile of the extracts was characterized by chromatography, spectrophotometry, and spectroscopy. The extracts were tested on cultures of mononuclear cells from four human subjects. These cells were pulsed with carboxyfluorescein succinimidyl ester, grown in triplicate in standard culture medium without (control) and with increasing concentrations of Lemna extracts. Flow cytometry was used to evaluate cell death and proliferation of the total mononuclear cell population and of CD4+, CD8+, B cell and monocyte populations. RESULTS: The Lemna extracts were not cytotoxic and did not cause cell necrosis or apoptosis in immune cells. At low concentrations, they induced very limited proliferation of CD4+ cells within 48 hours. At high concentrations, they induced proliferation of CD8+ cells and B lymphocytes within 48 hours. CONCLUSIONS: Unfortunately, we failed to confirm any immunomodulatory activity of Lemna extracts. Growth and death rates of human immune cells were not significantly affected by adding Lemna extracts to the culture medium.


Asunto(s)
Araceae , Inmunomodulación/efectos de los fármacos , Inmunomodulación/inmunología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/inmunología , Extractos Vegetales/farmacología , Araceae/genética , Células Cultivadas , Humanos , Fitoquímicos/genética , Fitoquímicos/aislamiento & purificación , Fitoquímicos/farmacología , Extractos Vegetales/genética , Extractos Vegetales/aislamiento & purificación
2.
Eur Rev Med Pharmacol Sci ; 25(1 Suppl): 67-73, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34890036

RESUMEN

A vast majority of COVID-19 patients experience fatigue, extreme tiredness and symptoms that persist beyond the active phase of the disease. This condition is called post-COVID syndrome. The mechanisms by which the virus causes prolonged illness are still unclear. The aim of this review is to gather information regarding post-COVID syndrome so as to highlight its etiological basis and the nutritional regimes and supplements that can mitigate, alleviate or relieve the associated chronic fatigue, gastrointestinal disorders and continuing inflammatory reactions. Naturally-occurring food supplements, such as acetyl L-carnitine, hydroxytyrosol and vitamins B, C and D hold significant promise in the management of post-COVID syndrome. In this pilot observational study, we evaluated the effect of a food supplement containing hydroxytyrosol, acetyl L-carnitine and vitamins B, C and D in improving perceived fatigue in patients who recovered from COVID-19 but had post-COVID syndrome characterized by chronic fatigue. The results suggest that the food supplement could proceed to clinical trials of its efficacy in aiding the recovery of patients with long COVID.


Asunto(s)
COVID-19/complicaciones , Suplementos Dietéticos , Acetilcarnitina/administración & dosificación , Adulto , Anciano , COVID-19/dietoterapia , COVID-19/patología , COVID-19/psicología , COVID-19/virología , Suplementos Dietéticos/efectos adversos , Fatiga/etiología , Femenino , Enfermedades Gastrointestinales/etiología , Humanos , Masculino , Persona de Mediana Edad , Alcohol Feniletílico/administración & dosificación , Alcohol Feniletílico/análogos & derivados , Proyectos Piloto , SARS-CoV-2/aislamiento & purificación , Autoinforme , Encuestas y Cuestionarios , Vitaminas/administración & dosificación , Síndrome Post Agudo de COVID-19
3.
Eur Rev Med Pharmacol Sci ; 25(1 Suppl): 74-80, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34890037

RESUMEN

OBJECTIVE: Face masks help contain the aerosol-mediated transmission of infectious viral particles released from individuals via cough and sneezes. However, the prolonged use of face masks has raised concerns regarding oral hygiene. Here, we present a mouthwash formulation based on α-cyclodextrin and hydroxytyrosol that can maintain healthy oral microbiota. MATERIALS AND METHODS: We isolated and cultured Candida albicans, Staphylococcus aureus, and a mix of Streptococcus sp., Staphylococcus sp. and Neisseria sp. from oral and throat swabs. The microorganisms were cultured in a standard medium with or without the mouthwash. To evaluate the effect of the mouthwash on the oral microbiota, the DNA from the saliva of 3 volunteers that used the mouthwash was extracted. Then, the DNA was amplified using primer pairs specific for bacterial and fungal DNA. Twelve further volunteers were offered to use the mouthwash and a questionnaire was submitted to them to assess the possible beneficial effects of mouthwash on halitosis and other oral disturbances. RESULTS: The bacteria and fungi cultured in media containing the mouthwash showed a growth reduction ranging from 20 to 80%. The PCR amplification of fungal and bacterial DNA extracted from volunteers that used the mouthwash showed a reduction of both bacteria and fungi. Volunteers that used the mouthwash reported a tendency towards a reduction of halitosis, gingival and mouth inflammation, and dry mouth. CONCLUSIONS: The use of a mouthwash containing α-cyclodextrin and hydroxytyrosol is not aggressive against oral mucosa; it is safe and effective to reduce the bacterial and fungal load due to the continuous use of face masks.


Asunto(s)
Máscaras/efectos adversos , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/microbiología , Antisépticos Bucales/administración & dosificación , Alcohol Feniletílico/análogos & derivados , alfa-Ciclodextrinas/administración & dosificación , Candida albicans/efectos de los fármacos , Candida albicans/crecimiento & desarrollo , Halitosis/etiología , Halitosis/microbiología , Halitosis/prevención & control , Humanos , Máscaras/tendencias , Neisseria/efectos de los fármacos , Neisseria/crecimiento & desarrollo , Alcohol Feniletílico/administración & dosificación , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Factores de Tiempo
4.
Artículo en Inglés | MEDLINE | ID: mdl-26312738

RESUMEN

A new UV-Visible spectroscopic method assisted with microwave for the determination of glucose in pharmaceutical formulations was developed. In this study glucose solutions were oxidized by ammonium molybdate in the presence of microwave energy and reacted with aniline to produce a colored solution. Optimum conditions of the reaction including wavelength, temperature, and pH of the medium and relative concentration ratio of the reactants were investigated. It was found that the optimal wavelength for the reaction is 610 nm, the optimal reaction time is 80s, the optimal reaction temperature is 160°C, the optimal reaction pH is 4, and the optimal concentration ratio aniline/ammonium molybdate solution was found to be 1:1. The limits of detection and quantification of the method are 0.82 and 2.75 ppm for glucose solution, respectively. The use of microwaves improved the speed of the method while the use of aniline improved the sensitivity of the method by shifting the wavelength.


Asunto(s)
Glucosa/análisis , Microondas , Espectrofotometría Ultravioleta/métodos , Compuestos de Anilina/análisis , Química Farmacéutica , Concentración de Iones de Hidrógeno , Límite de Detección , Molibdeno/análisis , Soluciones , Temperatura , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...